Clay Siegall Inherent Desire to Make an Impact through Cancer Research

What do news releases say about their experiences with Clay Siegall? Please name any blog you source.

Years of experience and dedication to the field of cancer research has ensured that Clay Siegall remains at the forefront in the battle against cancer. Since its inception in 1988 by Clay Siegall, Seattle Genetics has had numerous in-roads in coming up with innovations necessary to champion different forms of cancer.

Currently, Clay Siegall holds the company’s president position, as well as the CEO and Chairman of the Board.

During the Clay Siegall tenure at Seattle Genetics, the company has managed to improve the lives of numerous cancer patients. However, the company has not only been focusing on treating cancer only as they have also been associated with the treatment of autoimmune diseases such as lupus.

With his Ph.D. in Genetics from George Washington University, Dr. Siegall has been committed to research on new advancements that are effective in the fight against cancer. The organization has therefore managed to come up with different antibody drugs including brentuximab vedotin that already has an FDA accreditation. Besides his research work, Dr. Siegall has portrayed great leadership skills especially in raising over $1.2 billion in funding for the organization’s activities.

These efforts have eventually caught the attention of the community and other stakeholders. According to a reporter at engadget who got the opportunity to listen to Siegall speak at an event, he was impressed by how passionate he is in coming up with advancements that shape patients lives whose world has been affected by cancer.

Arthur Siegall has managed the work with other cancer research organizations such as Bristol Myers Squibb, The National Cancer Institute, and the National Institute of Health to bolster his attempts to eradicate the disease. His highly-prized advanced cancer treatments are currently available in over 65 countries and have sold over $325 million, but despite this achievement, he is not relenting anytime soon.

In tune with his passion for research, you will find DR. Siegall following up on the latest trends that affect such quests for advancements for instance the recent budget cuts by the government slated for research or the renewed energy by researchers to enforce integrity in the research world, all of which can be found on his blog.

 

You Might Also Like